| Applicant | Tradename | Generic Name | NDA | Approval Date | Exclusivity Expiration | Patented / Exclusive Use | | Glaxo Grp Ltd | ALTABAX | retapamulin | 022055 | Apr 12, 2007 | Apr 12, 2012 | NEW CHEMICAL ENTITY | | Boehringer Ingelheim | MOBIC | meloxicam | 020938 | Apr 13, 2000 | Aug 11, 2012 | ORPHAN DRUG EXCLUSIVITY | | Boehringer Ingelheim | MOBIC | meloxicam | 020938 | Aug 23, 2000 | Aug 11, 2012 | ORPHAN DRUG EXCLUSIVITY | | Boehringer Ingelheim | MOBIC | meloxicam | 021530 | Jun 1, 2004 | Aug 11, 2012 | ORPHAN DRUG EXCLUSIVITY | | Ar Holding Co Inc | QUALAQUIN | quinine sulfate | 021799 | Aug 12, 2005 | Aug 12, 2012 | ORPHAN DRUG EXCLUSIVITY |
|